// App-Quantinova.ai

PB0837 : Two-year Update on the WFH World Bleeding Disorders Registry

Researchers

Presenter

  • M. Naccache

Principal Investigators

  • D. Coffin

  • W. Youttananukorn

  • E. Tootoonchian

  • V. Byams

  • S. Diop

  • C. Hermans

  • D. Noone

  • J. O'Hara

  • G.F. Pierce

  • A. Iorio

  • B. Konkle

  • E. Ayoub

Medical Centers

  • World Federation of Hemophilia, Montreal, Canada

  • Centers for Disease Control and Prevention, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Atlanta, United States

  • Cheikh Anta Diop University, Dakar, Senegal

  • St-Luc University Hospital, Haemophilia Clinic, Division of Haematology, Brussels, Belgium

  • European Haemophilia Consortium, Burssels, Belgium

  • HCD Economics, Daresbury, United Kingdom

  • Bloodworks Northwest, Seattle, United States

Locations

  • Canada

  • United States

  • Senegal

  • Belgium

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Multinational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A